Tirzepatide 99.828% Purity — Qingdao Saber Technology Pharma Qst Certificate of Analysis
Test date
2026-06-26
Purity
99.83%
99.828%
Batch / lot
Unknown
Lab
Qingdao Saber Technology (QST)
Quantity
label
30mg
tested
33.01mg
Qty vs label
+10.0%
Endotoxins
—
Test score
—
Manufacturer
Qingdao Saber Technology Pharma Qst
Certificate
Test report image
Certificate scan as published.
Source
Community submission
✓ Artifact capturedWe have the certificate image — you can verify it loads from the upstream lab and matches the artifact below.
- Dose
- 30mg
- Catalogued
- 2026-06-27
OCR text
Raw extracted text
OCR text
Raw extracted text
Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display.
TEST REPORT JANOSHIK E-mail: [EMAIL_REDACTED] Web: www.janoshik.com Task Number #195214 Testing ordered > 13 JUN '26 Sample received > 18 JUN '26 Client [EMAIL_REDACTED] Sample Tirz 30 Manufacturer Qingdao Saber Technology (QST) [NAME_REDACTED] description > See picture or pictures attached. Tests requested > [NAME_REDACTED] peptide blind test (Semaglutide, Tirzepatide and Retatrutide) Results > Tirzepatide 33.01 mg Purity 99.828% Comments > Analysis conducted > 26 JUN 2026 Signature > Verify this test at www.janoshik.com/verify/ with the following unique key W2JNSQAKJW5Z
This COA is part of TitrateLab's community-trust corpus.
See more from Qingdao Saber Technology Pharma Qst
or learn how trust scores are computed on the
methodology page.
New to lab reports?
How to read a COA →